{"id":193816,"date":"2024-07-31T14:26:18","date_gmt":"2024-07-31T19:26:18","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/07\/study-identifies-protein-that-affects-health-of-gut-microbiota-and-response-to-bacterial-infection"},"modified":"2024-07-31T14:26:18","modified_gmt":"2024-07-31T19:26:18","slug":"study-identifies-protein-that-affects-health-of-gut-microbiota-and-response-to-bacterial-infection","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/07\/study-identifies-protein-that-affects-health-of-gut-microbiota-and-response-to-bacterial-infection","title":{"rendered":"Study identifies protein that affects health of gut microbiota and response to bacterial infection"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/study-identifies-protein-that-affects-health-of-gut-microbiota-and-response-to-bacterial-infection2.jpg\"><\/a><\/p>\n<p>Future studies can now be designed to understand the discovery in greater depth and use it to develop treatments. \u201cThe essential next step is to investigate the efficacy of IL-22BP inhibitors in animal models and possibly in clinical trials to treat severe intestinal infections,\u201d Fachi said. Another possibility will be to explore how different types and quantities of food fiber affect short-chain fatty acid production. \u201cThe composition of gut microbiota in the absence of IL-22BP can provide valuable information,\u201d he added.<\/p>\n<p>Gut microbiota modulation may benefit other intestinal inflammatory conditions, such as Crohn\u2019s disease and ulcerative colitis, as well as infections caused by other pathogens.<\/p>\n<p>\u201cFinding out how IL-22 interacts with other molecules and immune system cells in the absence of IL-22BP will help us better understand its function in intestinal immunity. Future studies could transform our understanding of the role of these proteins in intestinal health and lead to the development of novel therapeutic strategies to prevent and treat intestinal infections,\u201d Vinolo said.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Future studies can now be designed to understand the discovery in greater depth and use it to develop treatments. \u201cThe essential next step is to investigate the efficacy of IL-22BP inhibitors in animal models and possibly in clinical trials to treat severe intestinal infections,\u201d Fachi said. Another possibility will be to explore how different types [\u2026]<\/p>\n","protected":false},"author":692,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1506,1495],"tags":[],"class_list":["post-193816","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-food","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/193816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/692"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=193816"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/193816\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=193816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=193816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=193816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}